Valneva SE Company Leadership
VALN Stock | USD 6.55 0.05 0.77% |
Valneva SE employs about 713 people. The company is managed by 17 executives with a total tenure of roughly 1664 years, averaging almost 97.0 years of service per executive, having 41.94 employees per reported executive. Analysis of Valneva SE's management performance can provide insight into the firm performance.
Valneva SE Management Team Effectiveness
The company has return on total asset (ROA) of (0.1919) % which means that it has lost $0.1919 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4411) %, meaning that it created substantial loss on money invested by shareholders. Valneva SE's management efficiency ratios could be used to measure how well Valneva SE manages its routine affairs as well as how well it operates its assets and liabilities. As of the 20th of July 2025, Return On Capital Employed is likely to grow to 0.04, while Return On Tangible Assets are likely to drop (0.03). At this time, Valneva SE's Non Currrent Assets Other are very stable compared to the past year. As of the 20th of July 2025, Intangible Assets is likely to grow to about 44.9 M, while Total Assets are likely to drop about 267.2 M.As of the 20th of July 2025, Common Stock Shares Outstanding is likely to grow to about 73.8 M, though Net Loss is likely to grow to (62.8 M).
Valneva SE Workforce Comparison
Valneva SE ADR is rated first in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2,328. Valneva SE totals roughly 713 in number of employees claiming about 31% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.43) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.12) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.12. Valneva SE ADR Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Valneva SE ADR Price Series Summation is a cross summation of Valneva SE price series and its benchmark/peer.
Valneva SE Notable Stakeholders
A Valneva SE stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Valneva SE often face trade-offs trying to please all of them. Valneva SE's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Valneva SE's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Thomas Lingelbach | CEO President | Profile | |
Katrin Dubischar | VP Vaccine | Profile | |
Vincent Dequenne | Chief Officer | Profile | |
Frederic Jacotot | General IP | Profile | |
JuanCarlos MD | Chief Officer | Profile | |
Gerald Strohmaier | VP Resource | Profile | |
Peter Buhler | Chief Officer | Profile | |
Christian Taucher | Head Affairs | Profile | |
Perry Celentano | Interim Officer | Profile | |
Joshua Drumm | Vice Relations | Profile | |
Dipal Patel | Chief Officer | Profile | |
Kendra Wergin | General Secretary | Profile | |
Susanne EderLingelbach | Head Operations | Profile | |
Laetitia BachelotFontaine | VP Relations | Profile | |
Petra Pesendorfer | Chief Officer | Profile | |
Franck MBA | Chief Officer | Profile | |
Hanneke Schuitemaker | Chief Officer | Profile |
About Valneva SE Management Performance
The success or failure of an entity such as Valneva SE ADR often depends on how effective the management is. Valneva SE management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Valneva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Valneva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.03) | (0.03) | |
Return On Capital Employed | 0.03 | 0.04 | |
Return On Assets | (0.02) | (0.03) | |
Return On Equity | (0.07) | (0.07) |
Valneva SE Workforce Analysis
Traditionally, organizations such as Valneva SE use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Valneva SE within its industry.Valneva SE Manpower Efficiency
Return on Valneva SE Manpower
Revenue Per Employee | 237.8K | |
Revenue Per Executive | 10M | |
Net Loss Per Employee | 17.2K | |
Net Loss Per Executive | 720.4K | |
Working Capital Per Employee | 258.7K | |
Working Capital Per Executive | 10.8M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valneva SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.30) | Revenue Per Share | Quarterly Revenue Growth 0.503 | Return On Assets | Return On Equity |
The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.